Trial of Computerized MET for Adolescent Substance Use
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01784653 |
Recruitment Status
:
Withdrawn
(No funding obtained.)
First Posted
: February 6, 2013
Last Update Posted
: April 12, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Drug Abuse Alcohol Abuse Nicotine Dependence | Behavioral: iMET Behavioral: MET | Phase 1 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 0 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Randomized Controlled Trial of Computerized MET for Adolescent Substance Use |
Study Start Date : | October 2013 |
Estimated Primary Completion Date : | January 2017 |
Arm | Intervention/treatment |
---|---|
No Intervention: Treatment as Usual
Patients will receive the usual care from the treatment program
|
|
Experimental: iMET
Participants will complete a self-guided computerized Motivational Enhancement Therapy
|
Behavioral: iMET
Self-completed, computerized motivational enhancement therapy
|
Experimental: MET
Clinician-delivered Motivational Enhancement Therapy
|
Behavioral: MET
Clinician-delivered Motivational Enhancement Therapy
|
- Treatment engagement [ Time Frame: 12 months ]We will compare the number of individual visits in the program, the number of group sessions completed, and the number of urine screens completed during a 12 month follow-up period by each participant in the three study arms.
- Days abstinent [ Time Frame: past-90-days ]We will calculate the past-90-days number of days abstinent from any substance use and from the primary substance and the number of weeks abstinent from any substance use.
- Driving/Riding Risk [ Time Frame: past-90-days ]We will compare group trends in prevalence and frequency of past-90-days Driving while impaired or Riding with an impaired driver.
- HIV Risk Behavior [ Time Frame: past-90-days ]We will compare group trends in prevalence and frequency of past-90-days HIV Risk Behaviors.
- Treatment process/quality [ Time Frame: 60 days ]We will compare completion of the 2 MET sessions, and completion of the third follow-up visit between the iMET and MET conditions.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 12 Years to 21 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- completed initial visit at the treatment program;
- be available to return for iMET/MET sessions (if assigned)
- be available to complete all follow-up measurements
- a past-12-month CRAFFT score >1
- have used substances on >6 days (not including tobacco use) during the 90 days preceding their visit
Exclusion Criteria:
- unable to speak and understand English, or read English at a 5th grade reading level
- youth deemed by the clinical team to require immediate hospitalization or referral to more intensive residential treatment

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01784653
United States, Massachusetts | |
Boston Children's Hospital | |
Boston, Massachusetts, United States, 02115 |
Principal Investigator: | Sion K Harris, PhD | Boston Children’s Hospital |
Responsible Party: | Sion Kim Harris, Co-Director, Center for Adolescent Substance Abuse Research, Boston Children's Hospital |
ClinicalTrials.gov Identifier: | NCT01784653 History of Changes |
Other Study ID Numbers: |
SKH R01 PA-13-077 |
First Posted: | February 6, 2013 Key Record Dates |
Last Update Posted: | April 12, 2017 |
Last Verified: | April 2017 |
Keywords provided by Sion Kim Harris, Boston Children's Hospital:
Substance abuse Drug abuse Alcohol abuse Tobacco Adolescent |
Additional relevant MeSH terms:
Tobacco Use Disorder Alcoholism Substance-Related Disorders |
Chemically-Induced Disorders Mental Disorders Alcohol-Related Disorders |